sb 203580 has been researched along with emerin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (emerin) | Trials (emerin) | Recent Studies (post-2010) (emerin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 377 | 1 | 139 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, CM; Ellis, JA; Holaska, JM | 1 |
1 other study(ies) available for sb 203580 and emerin
Article | Year |
---|---|
MAPK signaling pathways and HDAC3 activity are disrupted during differentiation of emerin-null myogenic progenitor cells.
Topics: Acetylation; Animals; Butadienes; Cell Differentiation; Flavonoids; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Imidazoles; MAP Kinase Signaling System; Membrane Proteins; Mice; Models, Biological; Muscle Development; Muscle Fibers, Skeletal; Myosin Heavy Chains; Nitriles; Nuclear Proteins; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Stem Cells; Theophylline | 2017 |